307 related articles for article (PubMed ID: 25983027)
1. First-in-man evaluation of the novel balloon delivery system STENTYS Xposition S for the self-apposing coronary artery stent: impact on longitudinal geographic miss during stenting.
Lu H; IJsselmuiden AJ; Grundeken MJ; Nassif M; de Vries AG; Weevers A; Scholte M; Spaargaren R; Wykrzykowska JJ; Tijssen JG; de Winter RJ; Koch KT
EuroIntervention; 2016 Mar; 11(12):1341-5. PubMed ID: 25983027
[TBL] [Abstract][Full Text] [Related]
2. Dutch multicenter experience using the STENTYS Xposition S self-apposing stent in complex coronary lesions.
Vlieger S; Simsek C; Balland A; Somi S; Jessurun G; Amoroso G; Kauer F; van Geuns RJ; IJsselmuiden A
Catheter Cardiovasc Interv; 2019 Dec; 94(7):966-971. PubMed ID: 30903739
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
Lu H; Grundeken MJ; Vos NS; IJsselmuiden AJJ; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; Amoroso G; de Winter RJ; Koch KT
EuroIntervention; 2017 Aug; 13(5):e572-e577. PubMed ID: 28191875
[TBL] [Abstract][Full Text] [Related]
4. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.
Verheye S; Ramcharitar S; Grube E; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Spaargaren R; Serruys PW; García-García HM; van Geuns RJ
EuroIntervention; 2011 Sep; 7(5):580-7. PubMed ID: 21930462
[TBL] [Abstract][Full Text] [Related]
5. STENTYS Self-Apposing sirolimus-eluting stent in ST-segment elevation myocardial infarction: results from the randomised APPOSITION IV trial.
van Geuns RJ; Yetgin T; La Manna A; Tamburino C; Souteyrand G; Motreff P; Koch KT; Vrolix M; IJsselmuiden A; Amoroso G; Berland J; Montalescot G; Teiger E; Christiansen EH; Spaargaren R; Wijns W
EuroIntervention; 2016 Feb; 11(11):e1267-74. PubMed ID: 26865444
[TBL] [Abstract][Full Text] [Related]
6. First-in-man (FIM) study of the Stentys bifurcation stent--30 days results.
Verheye S; Grube E; Ramcharitar S; Schofer JJ; Witzenbichler B; Kovac J; Hauptmann KE; Agostoni P; Wiemer M; Lefèvre T; Serruys PW; van Geuns RJ
EuroIntervention; 2009 Mar; 4(5):566-71. PubMed ID: 19378675
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study.
Amoroso G; van Geuns RJ; Spaulding C; Manzo-Silberman S; Hauptmann KE; Spaargaren R; García-García HM; Serruys PW; Verheye S
EuroIntervention; 2011 Aug; 7(4):428-36. PubMed ID: 21764660
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of self-apposing Stentys drug-eluting stent in left main coronary artery PCI: Multicentre LM-STENTYS registry.
Wańha W; Mielczarek M; Smolka G; Roleder T; Jaguszewski M; Ciećwierz D; Tomasiewicz B; Kubler P; Gorol J; Chmielecki M; Bartuś S; Navarese EP; Kasprzak M; Sukiennik A; Kubica J; Lekston A; Hawranek M; Reczuch K; Gruchała M; Ochała A; Wojakowski W
Catheter Cardiovasc Interv; 2019 Mar; 93(4):574-582. PubMed ID: 30311397
[TBL] [Abstract][Full Text] [Related]
9. Clinical performance of a dedicated self-apposing stent for the treatment of left main stem disease. Results of the left Main AngioplasTy wIth a Self-apposing StEnt - the MATISSE study.
Cortese B; Montefusco A; D'Ascenzo F; La Manna A; Andò G; Bisceglia T; Secco GG; Meyer-Gessner M; Wańha W; Sganzerla P; Napodano M; Di Palma G; Latini RA; Tamburino C; Orrego PS; Baumbach A
Cardiovasc Revasc Med; 2018; 19(7 Pt B):831-836. PubMed ID: 29661597
[TBL] [Abstract][Full Text] [Related]
10. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
11. One-Year Clinical Outcomes of Patients Presenting With ST-Segment Elevation Myocardial Infarction Caused by Bifurcation Culprit Lesions Treated With the Stentys Self-Apposing Coronary Stent: Results From the APPOSITION III Study.
Grundeken MJ; Lu H; Vos N; IJsselmuiden A; van Geuns RJ; Wessely R; Dengler T; La Manna A; Silvain J; Montalescot G; Spaargaren R; Tijssen JGP; de Winter RJ; Wykrzykowska JJ; Amoroso G; Koch KT
J Invasive Cardiol; 2017 Aug; 29(8):253-258. PubMed ID: 28756418
[TBL] [Abstract][Full Text] [Related]
12. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
13. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience.
Montefusco A; De Filippo O; Gili S; Mancone M; Calcagno S; Cirillo P; Esposito G; Poli A; Ferrara E; Smolka G; Wanha W; Palmieri C; Pastormerlo LE; Baumbach A; Sganzerla P; Tamburino C; Bruno F; Secco GG; Nicolino A; Yew KL; di Palma G; Wojakowski W; Sardella G; Rinaldi M; Cortese B; D'Ascenzo F
Coron Artery Dis; 2020 Jan; 31(1):27-34. PubMed ID: 31658146
[TBL] [Abstract][Full Text] [Related]
14. First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial.
Qian J; Xu B; Lansky AJ; Yang YJ; Qiao SB; Wu YJ; Chen J; Hu FH; Yang WX; Mintz GS; Leon MB; Gao RL
Chin Med J (Engl); 2012 Mar; 125(6):970-6. PubMed ID: 22613516
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcome after implantation of the self-expandable STENTYS stent in a large, multicenter cohort.
Gaede L; Liebetrau C; Dörr O; Blumenstein J; Elsässer A; Hamm CW; Möllmann H; Schlundt C; Nef HM; Achenbach S
Coron Artery Dis; 2017 Nov; 28(7):588-596. PubMed ID: 28704242
[TBL] [Abstract][Full Text] [Related]
16. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
[TBL] [Abstract][Full Text] [Related]
17. The Glider registry.
Secco GG; Rittger H; Hoffmann S; Richardt G; Abdel-Wahab M; Reinecke H; Lotan C; Werner G; Sievert H; Foin N; Di Mario C
Catheter Cardiovasc Interv; 2017 Jan; 89(1):E1-E6. PubMed ID: 23729282
[TBL] [Abstract][Full Text] [Related]
18. Clinical and angiographic outcomes following first-in-man implantation of a novel thin-strut low-profile fixed-wire stent: the Svelte Coronary Stent Integrated Delivery System first-in-man trial.
Diletti R; Garcia-Garcia HM; Bourantas CV; van Geuns RJ; Van Mieghem NM; Agostoni P; Muramatsu T; Farooq V; Spencer R; De Schepper J; Pomeranz M; Stella P; Serruys PW
EuroIntervention; 2013 May; 9(1):125-34. PubMed ID: 23685300
[TBL] [Abstract][Full Text] [Related]
19. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study.
Kubo T; Imanishi T; Kitabata H; Kuroi A; Ueno S; Yamano T; Tanimoto T; Matsuo Y; Masho T; Takarada S; Tanaka A; Nakamura N; Mizukoshi M; Tomobuchi Y; Akasaka T
JACC Cardiovasc Imaging; 2008 Jul; 1(4):475-84. PubMed ID: 19356470
[TBL] [Abstract][Full Text] [Related]
20. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
Kandzari DE; Mauri L; Popma JJ; Turco MA; Gurbel PA; Fitzgerald PJ; Leon MB
JACC Cardiovasc Interv; 2011 May; 4(5):543-50. PubMed ID: 21596327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
